Cynapsus Therapeutics (NASDAQ:CYNA) +117.9% AH after agreeing to be acquired by privately-held Sunovion Pharmaceuticals for $40.50/share in cash, or ~$624M.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.